A Carcinogenic Potency Database of the Standardized Results of Animal Bioassays

Overview

Journal Environ Health Perspect

Date 1984 Dec 1

PMID 6525996

Citations 63

Authors

L S Gold

C B Sawyer

R Magaw

G M Backman

M de Veciana

R Levinson

N K HOOPER

W R Havender

L Bernstein

R Peto

Affiliations

Soon will be listed here.

Abstract

The preceding paper described our numerical index of carcinogenic potency, the TD50 and the statistical procedures adopted for estimating it from experimental data. This paper presents the Carcinogenic Potency Database, which includes results of about 3000 long-term, chronic experiments of 770 test compounds. Part II is a discussion of the sources of our data, the rationale for the inclusion of particular experiments and particular target sites, and the conventions adopted in summarizing the literature. Part III is a guide to the plot of results presented in Part IV. A number of appendices are provided to facilitate use of the database. The plot includes information about chronic cancer tests in mammals, such as dose and other aspects of experimental protocol, histopathology and tumor incidence, TD50 and its statistical significance, dose response, author's opinion and literature reference. The plot readily permits comparisons of carcinogenic potency and many other aspects of cancer tests; it also provides quantitative information about negative tests. The range of carcinogenic potency is over 10 million-fold.

Citing Articles

Developing a pragmatic consensus procedure supporting the ICH S1B(R1) weight of evidence carcinogenicity assessment.

Bassan A, Steigerwalt R, Keller D, Beilke L, Bradley P, Bringezu F Front Toxicol. 2024; 6:1370045.

PMID: 38646442 PMC: 11027748. DOI: 10.3389/ftox.2024.1370045.

A science-based agenda for health-protective chemical assessments and decisions: overview and consensus statement.

Woodruff T, Rayasam S, Axelrad D, Koman P, Chartres N, Bennett D Environ Health. 2023; 21(Suppl 1):132.

PMID: 36635734 PMC: 9835243. DOI: 10.1186/s12940-022-00930-3.

Evaluating the utility of the Threshold of Toxicological Concern (TTC) and its exclusions in the biocompatibility assessment of extractable chemical substances from medical devices.

Patlewicz G, Nelms M, Rua D Comput Toxicol. 2022; 24:1-11.

PMID: 36405647 PMC: 9671081. DOI: 10.1016/j.comtox.2022.100246.

What Makes a Potent Nitrosamine? Statistical Validation of Expert-Derived Structure-Activity Relationships.

Thomas R, Tennant R, Oliveira A, Ponting D Chem Res Toxicol. 2022; 35(11):1997-2013.

PMID: 36302501 PMC: 9682520. DOI: 10.1021/acs.chemrestox.2c00199.

Toxic Substances Control Act (TSCA) Implementation: How the Amended Law Has Failed to Protect Vulnerable Populations from Toxic Chemicals in the United States.

Rayasam S, Koman P, Axelrad D, Woodruff T, Chartres N Environ Sci Technol. 2022; 56(17):11969-11982.

PMID: 35980084 PMC: 9454241. DOI: 10.1021/acs.est.2c02079.

References

Cohen S, Erturk E, Von Esch A, Corvetti A, Bryan G . Carcinogenicity of 5-nitrofurans and related compounds with amino-heterocyclic substituents. J Natl Cancer Inst. 1975; 54(4):841-50. View

Wogan G, Paglialunga S, Newberne P . Carcinogenic effects of low dietary levels of aflatoxin B1 in rats. Food Cosmet Toxicol. 1974; 12(5-6):681-5. DOI: 10.1016/0015-6264(74)90239-9. View

SARLES M, VANDEGRIFT W . Chronic oral toxicity and related studies on animals with the insecticide and pyrethrum synergist, piperonyl butoxide. Am J Trop Med Hyg. 1952; 1(5):862-83. DOI: 10.4269/ajtmh.1952.1.862. View

Kuhara K, Takanashi H, Hirono I, Furuya T, Asada Y . CArcinogenic activity of clivorine, a pyrrolizidine alkaloid isolated from Ligularia dentata. Cancer Lett. 1980; 10(2):117-22. DOI: 10.1016/0304-3835(80)90034-8. View

Grasso P, Lansdown A, Kiss I, Gaunt I, Gangolli S . Nodular hyperplasia in the rat liver following prolonged feeding of Ponceau MX. Food Cosmet Toxicol. 1969; 7(5):425-42. DOI: 10.1016/s0015-6264(69)80423-2. View

Toth B, WALLCAVE L, Patil K, Schmeltz I, Hoffmann D . Induction of tumors in mice with the herbicide succinic acid 2,2-dimethylhydrazide. Cancer Res. 1977; 37(10):3497-500. View

Ito N, Nagasaki H, Aoe H, Sugihara S, Miyata Y . Development of hepatocellular carcinomas in rats treated with benzene hexachloride. J Natl Cancer Inst. 1975; 54(3):801-5. View

Schroeder H, Mitchener M . Life-term effects of mercury, methyl mercury, and nine other trace metals on mice. J Nutr. 1975; 105(4):452-8. DOI: 10.1093/jn/105.4.452. View

Horie A, Hohchi S, Kuratsune M . Carcinogenesis in the esophagus. II. Experimental production of esophageal cancer by administration of ethanolic solution of carcinogens. Gan. 1965; 56(5):429-41. View

10.

Cohen S, Lower Jr G, Erturk E, Bryan G . Comparative carcinogenicity in Swiss mice of N-(4-(5-nitro-2-furyl)-2-thiazolyl)acetamide and structurally related 5-nitrofurans and 4-nitrobenzenes. Cancer Res. 1973; 33(7):1593-7. View

11.

DEICHMANN W, Macdonald W, Anderson W, Bernal E . Adenocarcinoma in the lungs of mice exposed to vapors of 3-nitro-3-hexene. Toxicol Appl Pharmacol. 1963; 5:445-56. DOI: 10.1016/0041-008x(63)90016-4. View

12.

Lijinsky W, Reuber M, Davies T, RIGGS C . Dose-response studies with nitroso-1,2,3,6-tetrahydropyridine and dinitrosohomopiperazine in F344 rats. Ecotoxicol Environ Saf. 1982; 6(6):513-27. DOI: 10.1016/0147-6513(82)90033-1. View

13.

POEL W, CIOCCO A, Doolittle D . Unusual neoplasms and hyperplastic lesions in "random-bred" mice derived from four-way crossed inbred lines. Cancer Res. 1968; 28(5):845-59. View

14.

FITZHUGH O, Nelson A, QUAIFE M . CHRONIC ORAL TOXICITY OF ALDRIN AND DIELDRIN IN RATS AND DOGS. Food Cosmet Toxicol. 1964; 2:551-62. DOI: 10.1016/s0015-6264(64)80354-0. View

15.

YAMAMOTO R, Williams G, Frankel H, WEISBURGER J . 8-hydroxyquinoline: chronic toxicity and inhibitory effect on the carcinogenicity of N-2-fluorenylacetamide. Toxicol Appl Pharmacol. 1971; 19(4):687-98. DOI: 10.1016/0041-008x(71)90300-0. View

16.

HIGHMAN B, GREENMAN D, Norvell M, Farmer J, SHELLENBERGER T . Neoplastic and preneoplastic lesions induced in female C3H mice by diets containing diethylstilbestrol or 17 beta-estradiol. J Environ Pathol Toxicol. 1980; 4(5-6):81-95. View

17.

Tomatis L, Turusov V, Charles R, Boiocchi M, Gati E . Liver tumours in CF-1 mice exposed for limited periods to technical DDT. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1974; 82(1):25-35. DOI: 10.1007/BF00304381. View

18.

DEICHMANN W, Macdonald W, Blum E, Bevilacqua M, RADOMSKI J, Keplinger M . Tumorigenicity of aldrin, dieldrin and endrin in the albino rat. IMS Ind Med Surg. 1970; 39(10):426-34. View

19.

Zung B . Psychometric properties of the MAST and two briefer versions. J Stud Alcohol. 1979; 40(9):845-59. DOI: 10.15288/jsa.1979.40.845. View

20.

Toth B, Nagel D, Patil K, Erickson J, Antonson K . Tumor induction with the N'-acetyl derivative of 4-hydroxymethyl-phenylhydrazine, a metabolite of agaritine of Agaricus bisporus. Cancer Res. 1978; 38(1):177-80. View